{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2017-0255</td><td>2017-03-24</td><td></td><td></td><td>,&nbsp; ,&nbsp; ,&nbsp; HC,&nbsp; </td></tr><tr><td>Act</td><td colspan=\"5\">Controlled Drugs and Substances Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Order Amending Schedule lll to the Controlled Drugs and Substances Act (Methylphenidate)</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Order Amending SCHEDULE III TO THE CONTROLLED DRUGS AND SUBSTANCES ACT (METHYLPHENIDATE) in order to (1) protect the health and safety of Canadians and to mitigate the risk of misuse of New psychoactive substances derived from methylphenidate, while allowing access for legitimate therapeutic, scientific and research purposes; and (2) enable Health Canada and law enforcement agencies to administer and enforce provisions of the Controlled Drugs and Substances Act and its regulations with respect to these substances.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2017-0044  <strong>Publication Date:</strong> 2017-04-05</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=34161&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2017-0255",
  "htmlHash": "812190283bd151542d457eaa8e43cf36",
  "attachments": [
    "34161"
  ],
  "date": "2017-03-24",
  "chapter": "",
  "bill": "",
  "department": ", , , HC, ",
  "act": "Controlled Drugs and Substances Act",
  "subject": "Order Amending Schedule lll to the Controlled Drugs and Substances Act (Methylphenidate)",
  "precis": "Order Amending SCHEDULE III TO THE CONTROLLED DRUGS AND SUBSTANCES ACT (METHYLPHENIDATE) in order to (1) protect the health and safety of Canadians and to mitigate the risk of misuse of New psychoactive substances derived from methylphenidate, while allowing access for legitimate therapeutic, scientific and research purposes; and (2) enable Health Canada and law enforcement agencies to administer and enforce provisions of the Controlled Drugs and Substances Act and its regulations with respect to these substances.",
  "registration": "Registration: SOR/ 2017-0044  Publication Date: 2017-04-05",
  "registration_type": "SOR",
  "registration_id": "2017-0044",
  "registration_publication_date": "2017-04-05"
}